chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her nerve was bad; Getting all sick, cold, sick and experiencing terrible side effects; Getting all sick, cold, sick and experiencing terrible side effects; Fatigue; Muscle ache; Nauseous; Felt awful; Can't eat all the day, no appetite; phobic something to drinking water; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received bnt162b2 (lot/batch number and expiration date not provided), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. No relevant medical history. The patient's concomitant medications were not reported. The patient experienced getting all sick, cold, sick and experiencing terrible side effects, fatigue, muscle ache, nauseous, cannot do anything, felt awful, cannot eat all the day, no appetite, phobic something to drinking water. The patient has been sick for three days now. The patient was a "senior" (not clarified) care giver at the nursing home. Everybody at nursing home at the nursing home got the shot and now everybody has cold and sick. She has only one day of work and she has to come into her job to take care of elderly people. As since current everybody is experiencing the terrible adverse, terrible side effects, everything. Fatigue, muscle ache everything. The bosses at her nursing home cannot give them three days or even seven days off of work after receiving a contract to give them shot. It was confirmed that the patient received the COVID vaccine. The patient also stated that they are off of that side effects. They are not interrupted not just the "arm" (not clarified) been there. The patient said she getting everything. She was getting all the side effects. So when they had this Pfizer drug shot "they didn't get seven days off of" (not clarified) work. If a person gets a shot, they are feeling fatigue, nauseous (incomprehensible voice). They can't do anything. They should be allowed to stay home from work. Right now everybody in the nursing home is feeling the adverse effect. The entire building. So, she was telling Pfizer to report the report is that all of sudden that the nursing home "seniors" (not clarified) and nurses they got the shot, they can't even get to work. The effects are so bad that they can't do anything. The patient also stated that fatigue, she had fatigue all day. The first day she got the shot her nerve was bad but the second day was everything fatigue. She felt awful, she could not eat, she had no appetite. She was phobic something to drinking water, she cannot eat all the day. "Fruit or something 5 I can eat" (incomprehensible voice)." When probed for the LOT#, the reporter stated, "No they did not give me anything. All they did is I think 037 I think it looks like a 'K' 20A. (further not clarified) like it says (further not clarified) 037K20A that's (further not clarified)." The outcome of the events was unknown.  Information on lot number/batch number was requested.
Pt brought to ED; found to be positive for COVID; from respiratory perspective pt was asymptomatic; encephalopathy; CT head was negative; dysphagia; aspirating when eating; family chose to allow comfort feeds and changed status to comfort care; dc'd to Hospice where pt passed away (facility and state withheld.)
This spontaneous report as received from a medical assistant refers to a 2 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 16-JUN-2014 the patient was vaccinated with second dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).
pt reports having sharp pains in the head lasting about ten seconds, and then going away before receiving the vaccine. but the frequency has increased since getting the vaccine
Staring into space started within 30 minutes. Fever lasted 3 days and controlled by Tylenol. Infant was not himself, did not smile or make eye contact for a few days.
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in an 81-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Nov-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 02-Nov-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Patient taken vaccine around noon time and by midnight he had side effects. Card and lot number was not provided by facility. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-748138 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2023: Live follow-up received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-748138:Different patient (Same vaccine)
10 days after vacinne I woke up with a red, sore Rash arm at the injection site . It?s about 3? x 3?. I am taking antihistamines and using an ice pack for swelling. I don?t know how long this is going to last, it?s been two days so far.
Member arrived at the vaccine facility for Pfizer 2nd dose appointment.  The nurse administered Moderna instead of Pfizer.   Dr. immediately notified and evaluated the patient. Patient was also informed of plan of care.  Patient remained in the observation  area  and it was uneventful.  No adverse reactions noted.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 16:45 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 62 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Coronary artery disease" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing); "asthma" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 ". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Indication=Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
4 cm x 4 cm erythema, warmth, and rash with induration. Headache.
Dentist vaxed staff & a few employees given 3 doses of Engerix-B & did not seroconvert;
Immediately following vaccination, pt experienced hives all over face, chest, and arms. Pt was given Benadryl approximately 20 minutes after symptoms appeared.
Pt began VIVOTIF, by second dose complains of severe N/V and diarrhea.
Headache, body chills, fever, body aches, sore throat, ears ringing/hurting, nausau
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: blurry vision, eyes rolled in head, almost fainted but did not lose consciousness, clamy skin-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Severe, Systemic: Weakness-Severe, Additional Details: pt informed us almost passed out right after 1st dose. had her drink water before. had pharmacist & tech there when shot was given. she immendiatedly started rolling eyes in head & looked ready to pass out. elevated her feet, kept talking to her, rubbed her arms. her boyfriend held her hand. never totally lost consciousness. once totally awake,  drank more water. still unsteady so remained seated. when tried to stand, HA & pressure. waited 1/2 hr. pt has no primary md.
Severe pain "10/10" in deltoid area rad. down biceps area also into shoulder/neck. This was flu shot #2 alt recall of first vaccine by manufacturer.
upper arm pain one day, next day, left lower thumb/palm muscle tight/painful. Lump has formed in past three weeks. Still tight/painful.
3/30/2021  Patient received 1st dose of Moderna vaccine at 11:35AM and subsequently discontinued dialysis treatment 58 minutes early due to being cold.  3/31/2021 Patient went to hospital at 2:28PM with admitting diagnosis of acute encephalopathy due to intra-cranial hemorrhage. 4/1/2021  Patient expired at 3:35AM with cause of death reported as intra-cranial hemorrhage.
Dizziness, drop in temperature, raise in blood pressure, fatigue, near-fainting, fever, fast heart beat.
Fever, chills, aches, nausea, diarrhea, general malaise.
Headaches, fevers, chills, pain at the site of vaccination. Weakness of the legs.
Extreme body ache, fatigue, alternating fever (38C), chills. Symptoms started at 3AM in the morning and continued till around 7PM.  The next day symptoms were gone.
Red spots on legs; Feels like needles in my veins, they sting; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red spots on legs) and PARAESTHESIA (Feels like needles in my veins, they sting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red spots on legs) and PARAESTHESIA (Feels like needles in my veins, they sting). At the time of the report, ERYTHEMA (Red spots on legs) and PARAESTHESIA (Feels like needles in my veins, they sting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported. No Treatment medications were provided.
patient received first dose of Shingrix on 30May2018; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 30th May 2018, batch number:ZY3X4 and expiry date: 28th April 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient received first dose of Shingrix on 30May2018).The outcome of the incomplete course of vaccination was unknown.   Additional Information: Receipt Date:23-AUG-2023 The reporter reported that patient due to loss of insurance coverage did not receive the second dose of Shingrix. He would now like to receive another dose, but at the time of reporting it had not been administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.  Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Patient received pfizer vaccine on 3/22/21 and 4/19/21. Presented to ER on 4/23/22. COVID positive on 4/19/22. admitted on 04/23/2022 with acute hypoxic respiratory failure secondary to COPD exacerbation prompted from COVID-19 infection. He did test positive to COVID following exposure.  Chest x-ray did not show evidence of pneumonia but he had bibasilar atelectasis. He was managed medically with steroids , antibiotics and bronchodilators. .Overall doing well.  Shortness of breath improved.  He was weaned off oxygen.  Oxygen walk test completed 04/20/2017 showed required no oxygen. He was discharged in stable condition back to facility on 04/27/2022 with plan to complete 5 more days of Decadron 6 mg daily, and azithromycin 500 mg daily for 3 more doses.
SkinRash & UrticariaPruritus Narrative:  Developed hives and urticaria about 2 hours after the second dose of the Moderna vaccine. Treated in the urgent room with famotidine and methylprednisolone. Took diphenhydramine at home.
pt recv vax & inj site became red, swollen, tender;pt devel fever of 100.2;
24hr p/vax had swelling w/induration & erythema @ injs ite;very tired w/ h/a & nausea evening of shot & all of next day;@ 72hr 25mm induration w/erythema @ inj site;
Information has been received from a registered nurse concerning an 11 year old male who on 07-APR-1998 at the age of 2 years was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot# 625128/0062H) first dose in the left thigh. The patient had no preexisting medical conditions. On 09-NOV-2007, the patient developed multiple lesions on trunk, hairline and arms. The patient was treated with over the counter comfort measures by the physician and recovered on an unspecified date. Additional information has been requested.
Facial swelling and temporary paralysis to left side of face started 1/10/21. Swelling lasted two days. Facial paralysis 24 hrs, and facial symmetry still not corrected as of 2/2/2021. Entire facial rash started 1/21/2021. Rash started on face and moved down neck and chest. I took Benadryl for three days, which didn?t help. I then started a steroid regimen. 40 mg for three days. 20 mg for three days. I took last dose on Friday, 1/29/21. Rash was resistant to steroid until day three of regimen. Mild shortness of breath occurred 1/23/21, and lasted no more than an hour.
Temperature 101 degrees, coughing, severe headache, chills, lethargic
Second Dose not received in allowed time; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose not received in allowed time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose not received in allowed time). On 26-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose not received in allowed time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
patient was just give the adjuvant of the Menveo vaccine versus it being mixed with the antigen; patient was just give the adjuvant of the Menveo vaccine versus it being mixed with the antigen; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional Information: GSK Receipt Date: 04-JAN-2023 Reporter's Comments: The GSK representative reported an adverse event with limited information. The reporter stated that a healthcare professional (HCP) at one of her accounts reported that, a patient was just given the adjuvant of the Menveo vaccine versus it being mixed with the antigen.  The reporter had no further information concerning the event, patient or vaccine. The reporter consented to follow up. Additional Supportive Information: The patient received Menveo vaccine without antigen part, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Patient developed high fever up to 104 degrees, with severe localized pain, vomiting, redness to the area, and a systemic inflammatory-response-like syndrome. He was hospitalized.
Significant pain and lack of mobility in left arm. Much more pain and limited mobility than is "regular" post vaccine. Note that the injection site seems very high relative to "standard."
injection site too low (injection site measures 3.5? from shoulder acromion process instead of medical guidelines 2?) on low deltoid and punctured vein  with immediate excess bleeding at vaccine site with resultant 3cm horizontal x3.5cm vertical Bruise Left upper Arm - and especially with concerns  whether the  mMRA-1273 administration was intravenously instead of intramuscular especially w concerns whether the  mMRA-1273 administration was intravenously instead of intramuscular especially with recent research articles highlighting potential harm of inadvertent IV mRNA vaccines causing myocarditis, pericarditis or being rendered less effective or ineffective as would be vulnerable to being inactivated intravascularly
joint aches; Tightness in the chest was reported as worsened; stomach ache after eating some yogurt this morning; stomach ache after eating some yogurt this morning; fever worsened; Joint stiffness worsened; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8727) via an unspecified route of administration, administered in right arm, on 28Mar2021 15:40 (age at vaccination 54-year-old) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included ongoing bladder infection from 10Mar2021. The patient's concomitant medications included nitrofurantoin (NITROFURANTOIN MACROCRYSTALS) by mouth taken for bladder infection from 22Mar2021 and ongoing, change in dose, this was a dose decrease from the previous dose. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205) via an unspecified route of administration, administered in right arm, on 07Mar2021 15:40 (age at vaccination 54-year-old), as DOSE 1, SINGLE for COVID-19 immunisation and experienced headaches. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that she already had her 2nd dose of the Pfizer COVID Vaccine 9 days ago, making this day number 10 after the 2nd vaccination. She is calling about potential side effects which started on the 7th day after getting vaccinated, specifically headaches, joint aches, and tightness of the chest. On 06Apr2021, she also had a fever and stomach aches. She heard that symptoms typically last 2-3 days after the vaccine. The patient wanted to know how long it took to potentially experience side effects and told most people that have had some side effects, those side effects appeared 1-3 days after the vaccinations. She also had a stomach-ache after eating some yogurt this morning on 06Apr2021. She left the office, got a thermometer and when she checked her temperature, she had a temperature. She also felt tightness in her chest on Sunday. The tightness in her chest started last week but is unsure of the specific date and it got worse on Sunday. The patient experienced Joint stiffness worsened and fatigue on 04Apr2021. The patient also experienced joint aches, stomach aches and fever worsened on 06Apr2021. On an unspecified date the patient experienced slight headache, tightness in the chest worsened. Caller reports that she thinks the previous antibiotic she was on, was probably the same thing that she is on now, the Nitrofurantoin macro, But not completely certain. The patient took Ibuprofen for the body aches and the headache. Caller clarifies that she means joint stiffness and aches, when she said body aches. The outcome of tightness in the chest worsened, joint stiffness, fever, stomach ache was not resolved, outcome of fatigue was resolving, outcome of joint aches was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Developed shingles; Nerve involvement; This non-serious case was reported by a other health professional via sales rep and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced shingles (Verbatim: Developed shingles) and neurological disorder nos (Verbatim: Nerve involvement). The outcome of the shingles and neurological disorder nos were not reported.   It was unknown if the reporter considered the shingles and neurological disorder nos to be related to Shingrix.     It was unknown if the company considered the shingles and neurological disorder nos to be related to Shingrix.   Additional Information: GSK receipt date: 31-JUL-2023 The health care professionals (HCP) reported that the patient developed shingles with a few days of post vaccination and had nerve involvement post vaccination of 3 to 4 weeks. The reporter agrees to follow up from GlaxoSmithKline.
pt adm to hosp 19NOV98 w/new onset sz;dx rapidly progressive necrotizing encephalitis;clinically thought to be most consistent w/mitochondrial cytopathy although studies pending;autopsy showed meningoenchephalitis w/hemophagocytosis
Patient was administered two hepatitis B vaccines at same time; 1 in the right art and 1 in the left arm both IM. Patient was notified immediately. Called patient next day; denies any adverse/side effects. Regional Nurse Manager was also notified immediately after event occurred.